Abstract
This guideline was developed by the American College of Cardiology (ACC), American Heart Association (AHA), and collaborating organizations (American Association of Cardiovascular and Pulmonary Rehabilitation, American Association Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association).2 The guideline committee included cardiologists, internists, epidemiologists, medical economists, patient representatives, and pediatricians.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 589-591 |
| Number of pages | 3 |
| Journal | JAMA Cardiology |
| Volume | 4 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2019 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention. / Grundy, Scott M; Stone, Neil J.
In: JAMA Cardiology, Vol. 4, No. 6, 01.06.2019, p. 589-591.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention
AU - Grundy, Scott M
AU - Stone, Neil J.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - This guideline was developed by the American College of Cardiology (ACC), American Heart Association (AHA), and collaborating organizations (American Association of Cardiovascular and Pulmonary Rehabilitation, American Association Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association).2 The guideline committee included cardiologists, internists, epidemiologists, medical economists, patient representatives, and pediatricians.
AB - This guideline was developed by the American College of Cardiology (ACC), American Heart Association (AHA), and collaborating organizations (American Association of Cardiovascular and Pulmonary Rehabilitation, American Association Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association).2 The guideline committee included cardiologists, internists, epidemiologists, medical economists, patient representatives, and pediatricians.
UR - http://www.scopus.com/inward/record.url?scp=85068096975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068096975&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2019.0911
DO - 10.1001/jamacardio.2019.0911
M3 - Article
VL - 4
SP - 589
EP - 591
JO - JAMA Cardiology
JF - JAMA Cardiology
SN - 2380-6583
IS - 6
ER -